{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:28:30Z","timestamp":1756312110982},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00105-017-3983-7","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T11:10:46Z","timestamp":1493291446000},"page":"497-511","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Morbus Still im Kindes- und Erwachsenenalter","Still\u2019s disease in children and adults"],"prefix":"10.1007","volume":"68","author":[{"given":"C. M.","family":"Hedrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Aringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,27]]},"reference":[{"issue":"1","key":"3983_CR1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clim.2015.04.018","volume":"159","author":"N Bruck","year":"2015","unstructured":"Bruck N, Schnabel A, Hedrich CM (2015) Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches. Clin Immunol 159(1):72\u201383","journal-title":"Clin Immunol"},{"issue":"11","key":"3983_CR2","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s00296-011-2249-4","volume":"32","author":"CM Hedrich","year":"2012","unstructured":"Hedrich CM, Bruck N, Fiebig B, Gahr M (2012) Anakinra: a\u00a0safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA). Rheumatol Int 32(11):3525\u20133530","journal-title":"Rheumatol Int"},{"issue":"5","key":"3983_CR3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0022-3476(68)80003-4","volume":"72","author":"JJ Calabro","year":"1968","unstructured":"Calabro JJ, Marchesano JM (1968) Rash associated with juvenile rheumatoid arthritis. J\u00a0Pediatr 72(5):611\u2013619","journal-title":"J Pediatr"},{"issue":"12","key":"3983_CR4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s001050050848","volume":"49","author":"C Sunderkotter","year":"1998","unstructured":"Sunderkotter C, Frieling U, Nashan D, Metze D (1998) Adult-onset Still\u2019s disease and its characteristic rash. Hautarzt 49(12):920\u2013924","journal-title":"Hautarzt"},{"issue":"7","key":"3983_CR5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","volume":"13","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Seve P (2014) Adult-onset Still\u2019s disease. Autoimmun Rev 13(7):708\u2013722","journal-title":"Autoimmun Rev"},{"issue":"1\u20132","key":"3983_CR6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/pr.2013.187","volume":"75","author":"CK Correll","year":"2014","unstructured":"Correll CK, Binstadt BA (2014) Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis. Pediatr Res 75(1\u20132):176\u2013183","journal-title":"Pediatr Res"},{"issue":"2","key":"3983_CR7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5114\/reum.2015.51511","volume":"53","author":"E Dudziec","year":"2015","unstructured":"Dudziec E, Pawlak-Bus K, Leszczynski P (2015) Adult-onset Still\u2019s disease as a\u00a0mask of Hodgkin lymphoma. Reumatologia 53(2):106\u2013110","journal-title":"Reumatologia"},{"issue":"1","key":"3983_CR8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autrev.2012.07.022","volume":"12","author":"A Martini","year":"2012","unstructured":"Martini A (2012) Systemic juvenile idiopathic arthritis. Autoimmun Rev 12(1):56\u201359","journal-title":"Autoimmun Rev"},{"issue":"7","key":"3983_CR9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","volume":"7","author":"ED Mellins","year":"2011","unstructured":"Mellins ED, Macaubas C, Grom AA (2011) Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol 7(7):416\u2013426","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"3983_CR10","first-page":"343","volume":"35","author":"EM Behrens","year":"2008","unstructured":"Behrens EM, Beukelman T, Gallo L et\u00a0al (2008) Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J\u00a0Rheumatol 35(2):343\u2013348","journal-title":"J Rheumatol"},{"key":"3983_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2016.02.010","volume":"69","author":"U Kalyoncu","year":"2016","unstructured":"Kalyoncu U, Solmaz D, Emmungil H et al (2016) Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still\u2019s disease: data from a\u00a0large multicenter cohort. J\u00a0Autoimmun 69:59\u201363","journal-title":"J Autoimmun"},{"issue":"2","key":"3983_CR12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.1780300209","volume":"30","author":"JJ Cush","year":"1987","unstructured":"Cush JJ, Medsger TA Jr., Christy WC, Herbert DC, Cooperstein LA (1987) Adult-onset Still\u2019s disease. Clinical course and outcome. Arthritis Rheum 30(2):186\u2013194","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3983_CR13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/berh.2002.0233","volume":"16","author":"K Oen","year":"2002","unstructured":"Oen K (2002) Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol 16(3):347\u2013360","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2 Pt 1","key":"3983_CR14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0022-3476(05)80427-5","volume":"120","author":"R Schneider","year":"1992","unstructured":"Schneider R, Lang BA, Reilly BJ et al (1992) Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis. J\u00a0Pediatr 120(2 Pt 1):200\u2013205","journal-title":"J Pediatr"},{"issue":"5","key":"3983_CR15","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.21774","volume":"54","author":"D Singh-Grewal","year":"2006","unstructured":"Singh-Grewal D, Schneider R, Bayer N, Feldman BM (2006) Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features. Arthritis Rheum 54(5):1595\u20131601","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3983_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12969-015-0047-3","volume":"13","author":"N Nirmala","year":"2015","unstructured":"Nirmala N, Brachat A, Feist E et al (2015) Gene-expression analysis of adult-onset Still\u2019s disease and systemic juvenile idiopathic arthritis is consistent with a\u00a0continuum of a\u00a0single disease entity. Pediatr Rheumatol Online\u00a0J 13(1):50. doi: 10.1186\/s12969-015-0047-3","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"3983_CR17","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/art.38615","volume":"66","author":"PA Nigrovic","year":"2014","unstructured":"Nigrovic PA (2014) Review: is there a\u00a0window of opportunity for treatment of systemic juvenile idiopathic arthritis? Arthritis Rheumatol 66(6):1405\u20131413","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"3983_CR18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","volume":"66","author":"W Jager de","year":"2007","unstructured":"de Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ (2007) Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a\u00a0cross-sectional study. Ann Rheum Dis 66(5):589\u2013598","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"3983_CR19","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/art.22981","volume":"56","author":"N Fall","year":"2007","unstructured":"Fall N, Barnes M, Thornton S et al (2007) Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum 56(11):3793\u20133804","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3983_CR20","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/art.22644","volume":"56","author":"EM Ogilvie","year":"2007","unstructured":"Ogilvie EM, Khan A, Hubank M, Kellam P, Woo P (2007) Specific gene expression profiles in systemic juvenile idiopathic arthritis. Arthritis Rheum 56(6):1954\u20131965","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3983_CR21","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","volume":"201","author":"V Pascual","year":"2005","unstructured":"Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J (2005) Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J\u00a0Exp Med 201(9):1479\u20131486","journal-title":"J Exp Med"},{"issue":"2","key":"3983_CR22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","volume":"63","author":"PA Nigrovic","year":"2011","unstructured":"Nigrovic PA, Mannion M, Prince FH et al (2011) Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum 63(2):545\u2013555","journal-title":"Arthritis Rheum"},{"issue":"4","key":"3983_CR23","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/art.38296","volume":"66","author":"SJ Vastert","year":"2014","unstructured":"Vastert SJ, de Jager W, Noordman BJ et al (2014) Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a\u00a0prospective cohort study. Arthritis Rheumatol 66(4):1034\u20131043","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"3983_CR24","first-page":"2071","volume":"31","author":"JW Verbsky","year":"2004","unstructured":"Verbsky JW, White AJ (2004) Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. J\u00a0Rheumatol 31(10):2071\u20132075","journal-title":"J Rheumatol"},{"issue":"5","key":"3983_CR25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.coi.2011.07.005","volume":"23","author":"BR Barker","year":"2011","unstructured":"Barker BR, Taxman DJ, Ting JP (2011) Cross-regulation between the IL-1beta\/IL-18 processing inflammasome and other inflammatory cytokines. Curr Opin Immunol 23(5):591\u2013597","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"3983_CR26","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/art.24750","volume":"60","author":"W Jager de","year":"2009","unstructured":"de Jager W, Vastert SJ, Beekman JM et al (2009) Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 60(9):2782\u20132793","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3983_CR27","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/art.38984","volume":"67","author":"F Benedetti De","year":"2015","unstructured":"De Benedetti F, Brunner H, Ruperto N et al (2015) Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: results from a\u00a0phase III trial. Arthritis Rheumatol 67(3):840\u2013848","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"3983_CR28","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.1780340912","volume":"34","author":"F Benedetti de","year":"1991","unstructured":"de Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio GR, Martini A (1991) Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum 34(9):1158\u20131163","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3983_CR29","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1210\/endo.142.11.8511","volume":"142","author":"F Benedetti De","year":"2001","unstructured":"De Benedetti F, Meazza C, Oliveri M et al (2001) Effect of IL-6 on IGF binding protein-3: a\u00a0study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. Endocrinology 142(11):4818\u20134826","journal-title":"Endocrinology"},{"issue":"3","key":"3983_CR30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.molimm.2011.08.026","volume":"49","author":"J Jin","year":"2011","unstructured":"Jin J, Samuvel DJ, Zhang X et al (2011) Coactivation of TLR4 and TLR2\/6 coordinates an additive augmentation on IL-6 gene transcription via p38MAPK pathway in U937 mononuclear cells. Mol Immunol 49(3):423\u2013432","journal-title":"Mol Immunol"},{"issue":"1\u20132","key":"3983_CR31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cccn.2004.02.023","volume":"344","author":"D Foell","year":"2004","unstructured":"Foell D, Frosch M, Sorg C, Roth J (2004) Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 344(1\u20132):37\u201351","journal-title":"Clin Chim Acta"},{"issue":"3","key":"3983_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2012.11.008","volume":"147","author":"C Kessel","year":"2013","unstructured":"Kessel C, Holzinger D, Foell D (2013) Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers. Clin Immunol 147(3):229\u2013241","journal-title":"Clin Immunol"},{"issue":"12","key":"3983_CR33","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1002\/art.24137","volume":"58","author":"H Wittkowski","year":"2008","unstructured":"Wittkowski H, Frosch M, Wulffraat N et al (2008) S100A12 is a\u00a0novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum 58(12):3924\u20133931","journal-title":"Arthritis Rheum"},{"issue":"1\u20133","key":"3983_CR34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12026-009-8150-5","volume":"47","author":"CM Hedrich","year":"2010","unstructured":"Hedrich CM, Bream JH (2010) Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res 47(1\u20133):185\u2013206","journal-title":"Immunol Res"},{"issue":"2","key":"3983_CR35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.clim.2012.02.005","volume":"143","author":"SR Hofmann","year":"2012","unstructured":"Hofmann SR, Rosen-Wolff A, Tsokos GC, Hedrich CM (2012) Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. Clin Immunol 143(2):116\u2013127","journal-title":"Clin Immunol"},{"issue":"2","key":"3983_CR36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clim.2015.09.013","volume":"161","author":"SR Hofmann","year":"2015","unstructured":"Hofmann SR, Kubasch AS, Ioannidis C et al (2015) Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1beta expression and release. Clin Immunol 161(2):300\u2013307","journal-title":"Clin Immunol"},{"issue":"1","key":"3983_CR37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clim.2012.07.012","volume":"145","author":"SR Hofmann","year":"2012","unstructured":"Hofmann SR, Morbach H, Schwarz T, Rosen-Wolff A, Girschick HJ, Hedrich CM (2012) Attenuated TLR4\/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression. Clin Immunol 145(1):69\u201376","journal-title":"Clin Immunol"},{"issue":"3","key":"3983_CR38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clim.2011.08.012","volume":"141","author":"SR Hofmann","year":"2011","unstructured":"Hofmann SR, Schwarz T, Moller JC et al (2011) Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin Immunol 141(3):317\u2013327","journal-title":"Clin Immunol"},{"issue":"5","key":"3983_CR39","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1186\/ar2041","volume":"8","author":"MS Fife","year":"2006","unstructured":"Fife MS, Gutierrez A, Ogilvie EM et\u00a0al (2006) Novel IL10 gene family associations with systemic juvenile idiopathic arthritis. Arthritis Res Ther 8(5):R148","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"3983_CR40","first-page":"912","volume":"28","author":"JC Moller","year":"2010","unstructured":"Moller JC, Paul D, Ganser G et\u00a0al (2010) IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA). Clin Exp Rheumatol 28(6):912\u2013918","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"3983_CR41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/gene.2008.24","volume":"9","author":"CJ Stock","year":"2008","unstructured":"Stock CJ, Ogilvie EM, Samuel JM, Fife M, Lewis CM, Woo P (2008) Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis. Genes Immun 9(4):349\u2013357","journal-title":"Genes Immun"},{"issue":"7","key":"3983_CR42","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","volume":"102","author":"D Fishman","year":"1998","unstructured":"Fishman D, Faulds G, Jeffery R et al (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J\u00a0Clin Invest 102(7):1369\u20131376","journal-title":"J Clin Invest"},{"issue":"11","key":"3983_CR43","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1002\/art.11300","volume":"48","author":"EM Ogilvie","year":"2003","unstructured":"Ogilvie EM, Fife MS, Thompson SD et al (2003) The \u2212174\u202fG allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a\u00a0multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis Rheum 48(11):3202\u20133206","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3983_CR44","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/art.10882","volume":"48","author":"F Benedetti De","year":"2003","unstructured":"De Benedetti F, Meazza C, Vivarelli M et al (2003) Functional and prognostic relevance of the \u2212173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 48(5):1398\u20131407","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3983_CR45","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#","volume":"44","author":"RP Donn","year":"2001","unstructured":"Donn RP, Shelley E, Ollier WE, Thomson W, British Paediatric Rheumatology Study Group (2001) A novel 5\u2032-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 44(8):1782\u20131785","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3983_CR46","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1529-0131(200201)46:1<232::AID-ART10059>3.0.CO;2-B","volume":"46","author":"C Meazza","year":"2002","unstructured":"Meazza C, Travaglino P, Pignatti P et\u00a0al (2002) Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum 46(1):232\u2013237","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3983_CR47","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/art.38877","volume":"67","author":"SM Wakil","year":"2015","unstructured":"Wakil SM, Monies DM, Abouelhoda M et\u00a0al (2015) Association of a\u00a0mutation in LACC1 with a\u00a0monogenic form of systemic juvenile idiopathic arthritis. Arthritis Rheumatol 67(1):288\u2013295","journal-title":"Arthritis Rheumatol"},{"issue":"52","key":"3983_CR48","doi-asserted-by":"crossref","first-page":"15970","DOI":"10.1073\/pnas.1520779112","volume":"112","author":"MJ Ombrello","year":"2015","unstructured":"Ombrello MJ, Remmers EF, Tachmazidou I et al (2015) HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. Proc Natl Acad Sci U S\u00a0A 112(52):15970\u201315975","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"3983_CR49","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/rheumatology\/34.10.984","volume":"34","author":"M Koeller","year":"1995","unstructured":"Koeller M, Kiener H, Simonitsch I et al (1995) Destructive lymphadenopathy and T\u2011lymphocyte activation in adult-onset Still\u2019s disease. Br J Rheumatol 34(10):984\u2013988","journal-title":"Br J Rheumatol"},{"issue":"10","key":"3983_CR50","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/rheumatology\/kes162","volume":"51","author":"E Omoyinmi","year":"2012","unstructured":"Omoyinmi E, Hamaoui R, Pesenacker A et\u00a0al (2012) Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis. Rheumatology (Oxford) 51(10):1881\u20131886","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"3983_CR51","first-page":"1133","volume":"34","author":"EM Behrens","year":"2007","unstructured":"Behrens EM, Beukelman T, Paessler M, Cron RQ (2007) Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J\u00a0Rheumatol 34(5):1133\u20131138","journal-title":"J Rheumatol"},{"issue":"4","key":"3983_CR52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(85)80072-X","volume":"106","author":"M Hadchouel","year":"1985","unstructured":"Hadchouel M, Prieur AM, Griscelli C (1985) Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J\u00a0Pediatr 106(4):561\u2013566","journal-title":"J Pediatr"},{"issue":"5","key":"3983_CR53","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","volume":"85","author":"S Sawhney","year":"2001","unstructured":"Sawhney S, Woo P, Murray KJ (2001) Macrophage activation syndrome: a\u00a0potentially fatal complication of rheumatic disorders. Arch Dis Child 85(5):421\u2013426","journal-title":"Arch Dis Child"},{"issue":"3","key":"3983_CR54","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/art.23270","volume":"58","author":"R Donn","year":"2008","unstructured":"Donn R, Ellison S, Lamb R, Day T, Baildam E, Ramanan AV (2008) Genetic loci contributing to hemophagocytic lymphohistiocytosis do not confer susceptibility to systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 58(3):869\u2013874","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3983_CR55","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/art.23734","volume":"58","author":"K Zhang","year":"2008","unstructured":"Zhang K, Biroschak J, Glass DN et al (2008) Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rheum 58(9):2892\u20132896","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3983_CR56","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","volume":"49","author":"SJ Vastert","year":"2010","unstructured":"Vastert SJ, van Wijk R, D\u2019Urbano LE et\u00a0al (2010) Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford) 49(3):441\u2013449","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"3983_CR57","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s10875-011-9583-x","volume":"31","author":"M Yanagimachi","year":"2011","unstructured":"Yanagimachi M, Goto H, Miyamae T et\u00a0al (2011) Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children. J\u00a0Clin Immunol 31(6):946\u2013951","journal-title":"J Clin Immunol"},{"issue":"4","key":"3983_CR58","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3899\/jrheum.100655","volume":"38","author":"M Yanagimachi","year":"2011","unstructured":"Yanagimachi M, Naruto T, Miyamae T et\u00a0al (2011) Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. J\u00a0Rheumatol 38(4):769\u2013774","journal-title":"J Rheumatol"},{"key":"3983_CR59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.12703\/P6-21","volume":"6","author":"T Beukelman","year":"2014","unstructured":"Beukelman T (2014) Treatment advances in systemic juvenile idiopathic arthritis. F1000prime Rep 6:21","journal-title":"F1000prime Rep"},{"issue":"6","key":"3983_CR60","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jbspin.2010.09.002","volume":"77","author":"P Quartier","year":"2010","unstructured":"Quartier P (2010) Current treatments for juvenile idiopathic arthritis. Joint Bone Spine 77(6):511\u2013516","journal-title":"Joint Bone Spine"},{"issue":"7","key":"3983_CR61","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/acr.21625","volume":"64","author":"EM DeWitt","year":"2012","unstructured":"DeWitt EM, Kimura Y, Beukelman T et al (2012) Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 64(7):1001\u20131010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"3983_CR62","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/acr.22343","volume":"66","author":"Y Kimura","year":"2014","unstructured":"Kimura Y, DeWitt EM, Beukelman T et\u00a0al (2014) Adding canakinumab to the Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for systemic juvenile idiopathic arthritis: comment on the article by DeWitt et\u00a0al. Arthritis Care Res (Hoboken) 66(9):1430\u20131431","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"3983_CR63","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jbspin.2006.12.004","volume":"74","author":"M Garcia-Carrasco","year":"2007","unstructured":"Garcia-Carrasco M, Fuentes-Alexandro S, Escarcega RO, Rojas-Rodriguez J, Escobar LE (2007) Efficacy of thalidomide in systemic onset juvenile rheumatoid arthritis. Joint Bone Spine 74(5):500\u2013503","journal-title":"Joint Bone Spine"},{"issue":"5","key":"3983_CR64","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","volume":"70","author":"P Quartier","year":"2011","unstructured":"Quartier P, Allantaz F, Cimaz R et al (2011) A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis 70(5):747\u2013754","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3983_CR65","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/acr.21901","volume":"65","author":"C Giampietro","year":"2013","unstructured":"Giampietro C, Ridene M, Lequerre T et al (2013) Anakinra in adult-onset Still\u2019s disease: long-term treatment in patients resistant to conventional therapy. Arthritis Care Res (Hoboken) 65(5):822\u2013826","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"39","key":"3983_CR66","doi-asserted-by":"crossref","first-page":"e1554","DOI":"10.1097\/MD.0000000000001554","volume":"94","author":"F Ortiz-Sanjuan","year":"2015","unstructured":"Ortiz-Sanjuan F, Blanco R, Riancho-Zarrabeitia L et al (2015) Efficacy of Anakinra in refractory adult-onset still\u2019s disease: multicenter study of 41 patients and literature review. Medicine (Baltimore) 94(39):e1554","journal-title":"Medicine (Baltimore)"},{"key":"3983_CR67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13023-015-0228-7","volume":"10","author":"L Rossi-Semerano","year":"2015","unstructured":"Rossi-Semerano L, Fautrel B, Wendling D et al (2015) Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a\u00a0nationwide survey. Orphanet J Rare Dis 10:19","journal-title":"Orphanet J Rare Dis"},{"issue":"25","key":"3983_CR68","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","volume":"367","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Brunner HI, Quartier P et\u00a0al (2012) Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N\u00a0Engl J Med 367(25):2396\u20132406","journal-title":"N Engl J Med"},{"issue":"2","key":"3983_CR69","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/art.33342","volume":"64","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Quartier P, Wulffraat N et al (2012) A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. Arthritis Rheum 64(2):557\u2013567","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3983_CR70","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.23620","volume":"58","author":"R Goldbach-Mansky","year":"2008","unstructured":"Goldbach-Mansky R, Shroff SD, Wilson M et al (2008) A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. Arthritis Rheum 58(8):2432\u20132442","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3983_CR71","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-157-8-201210160-00003","volume":"157","author":"PJ Hashkes","year":"2012","unstructured":"Hashkes PJ, Spalding SJ, Giannini EH et al (2012) Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a\u00a0randomized trial. Ann Intern Med 157(8):533\u2013541","journal-title":"Ann Intern Med"},{"issue":"8","key":"3983_CR72","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","volume":"58","author":"HM Hoffman","year":"2008","unstructured":"Hoffman HM, Throne ML, Amar NJ et al (2008) Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum 58(8):2443\u20132452","journal-title":"Arthritis Rheum"},{"issue":"12","key":"3983_CR73","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1136\/annrheumdis-2012-201409","volume":"71","author":"O Petryna","year":"2012","unstructured":"Petryna O, Cush JJ, Efthimiou P (2012) IL-1 Trap rilonacept in refractory adult onset Still\u2019s disease. Ann Rheum Dis 71(12):2056\u20132057","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"3983_CR74","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F Benedetti De","year":"2012","unstructured":"De Benedetti F, Brunner HI, Ruperto N et\u00a0al (2012) Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N\u00a0Engl J Med 367(25):2385\u20132395","journal-title":"N Engl J Med"},{"issue":"3","key":"3983_CR75","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/art.20944","volume":"52","author":"S Yokota","year":"2005","unstructured":"Yokota S, Miyamae T, Imagawa T et al (2005) Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 52(3):818\u2013825","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3983_CR76","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1385\/CRIAI:28:3:231","volume":"28","author":"S Yokota","year":"2005","unstructured":"Yokota S, Miyamae T, Imagawa T, Katakura S, Kurosawa R, Mori M (2005) Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis. Clin Rev Allergy Immunol 28(3):231\u2013238","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"3983_CR77","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/art.38398","volume":"66","author":"F Ortiz-Sanjuan","year":"2014","unstructured":"Ortiz-Sanjuan F, Blanco R, Calvo-Rio V et al (2014) Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still\u2019s disease: multicenter retrospective open-label study of thirty-four patients. Arthritis Rheumatol 66(6):1659\u20131665","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"3983_CR78","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/acr.20319","volume":"63","author":"X Puechal","year":"2011","unstructured":"Puechal X, DeBandt M, Berthelot JM et\u00a0al (2011) Tocilizumab in refractory adult Still\u2019s disease. Arthritis Care Res (Hoboken) 63(1):155\u2013159","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"3983_CR79","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/rheumatology\/ket250","volume":"53","author":"IA Al-Homood","year":"2014","unstructured":"Al-Homood IA (2014) Biologic treatments for adult-onset Still\u2019s disease. Rheumatology (Oxford) 53(1):32\u201338","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"3983_CR80","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3899\/jrheum.090952","volume":"36","author":"RA Russo","year":"2009","unstructured":"Russo RA, Katsicas MM (2009) Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents. J\u00a0Rheumatol 36(5):1078\u20131082","journal-title":"J Rheumatol"},{"issue":"2","key":"3983_CR81","first-page":"265","volume":"28","author":"L Quartuccio","year":"2010","unstructured":"Quartuccio L, Maset M, De Vita S (2010) Efficacy of abatacept in a\u00a0refractory case of adult-onset Still\u2019s disease. Clin Exp Rheumatol 28(2):265\u2013267","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"3983_CR82","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/rheumatology\/keu027","volume":"53","author":"WS Lee","year":"2014","unstructured":"Lee WS, Yoo WH (2014) Rituximab for refractory adult-onset Still\u2019s disease with thrombotic microangiopathy. Rheumatology (Oxford) 53(9):1717\u20131718","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"3983_CR83","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.22656","volume":"56","author":"DM Brinkman","year":"2007","unstructured":"Brinkman DM, de Kleer IM, ten Cate R et al (2007) Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a\u00a0prospective clinical trial. Arthritis Rheum 56(7):2410\u20132421","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3983_CR84","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10875-007-9120-0","volume":"27","author":"DM Brinkman","year":"2007","unstructured":"Brinkman DM, Jol-van der Zijde CM, ten Dam MM et al (2007) Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines. J\u00a0Clin Immunol 27(6):647\u2013658","journal-title":"J Clin Immunol"},{"key":"3983_CR85","first-page":"262","volume":"6","author":"BZ Shao","year":"2015","unstructured":"Shao BZ, Xu ZQ, Han BZ, Su DF, Liu C (2015) NLRP3 inflammasome and its inhibitors: a\u00a0review. Front Pharmacol 6:262","journal-title":"Front Pharmacol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-017-3983-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-3983-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-3983-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T20:23:31Z","timestamp":1719174211000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-017-3983-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["3983"],"URL":"https:\/\/doi.org\/10.1007\/s00105-017-3983-7","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]}}}